/

Companies / Rare Genomics Institute

Rare Genomics Institute

United States

Rare Genomics Institute is a non-profit that bridges the healthcare gap for undiagnosed rare disease patients through international patient advocacy, clinical genomic sequencing, and partnerships with researchers and biomedical technology companies.

Rare Genomics Institute, based in United States, has 1 investor on file, among them Praxis. Its site was last checked 18 Nov 2026: site answers.

Investors

1 investor on file
InvestorEvidenceType
PraxisPortfolio pageAccelerator

More from Praxis

326 companies on its checked portfolio

Its portfolio leans to Education (22%), Consumer (17%), Healthcare & Biotech (17%).

See Praxis' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Rare Genomics Institute and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Praxis adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/raregenomics.org/investors

# also
GET /v1/companies/raregenomics.org
GET /v1/companies/raregenomics.org/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing